Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

NCT06008977 is registered in ClinicalTrials.gov with AdventHealth Translational Research Institute as lead sponsor.

NCT NCT06008977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06008977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exercise to Boost Response to Checkpoint Blockade Immunotherapy
Lead sponsor
AdventHealth Translational Research Institute
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 3, 2024
Completion date
December 31, 2026
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous melanoma, cutaneous squamous cell carcinoma, merkel cell carcinoma